Gema Diagnostics

Gema is developing noninvasive human oocyte and embryo selection methods to fundamentally improve the prospects for in vitro fertilization.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Ann Arbor, MI, USA
  • Currency USD
  • Founded September 2005
  • Employees 2
  • Website gemadx.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free